Trial intelligence / Profile preview

Magnesium Sulphate vs Dexmedetomidine for Propofol Sedation in ERCP

NCT02684019Phase 3Completed

Sponsor
Theodor Bilharz Research Institute
Start
Jan 2016
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium sulfate in Procedural sedation (PS), sponsored by Theodor Bilharz Research Institute. Started Jan 2016; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT02684019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02684019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call